Zhao Yanyan, Liu Zhongyu, Yu Ling, Liu Sai, Yan Hong, Zhang Yan, Yao Yuanqing
Department of Gynaecology and Obstetrics, The First Medical Center of PLA General Hospital, Beijing, China.
Department of Gynaecology and Obstetrics, The First Hospital of Jiamusi University, Jiamusi, China.
Wideochir Inne Tech Maloinwazyjne. 2020 Mar;15(1):171-175. doi: 10.5114/wiitm.2019.89337. Epub 2019 Oct 23.
The objective of this study was to assess the clinical effectiveness of robotic surgery for obese patients (body mass index (BMI) ≥ 30 kg/m) with early stage endometrial cancer.
This study is a retrospective review of women who underwent robotic surgery for early-stage endometrial cancer from 2008 to 2017. Patients were subdivided into those with BMI < 30 kg/m (group 1), and those with BMI ≥ 30 kg/m (group 2). Basic demographics and perioperative period outcomes were extracted from the medical records and compared.
Group 1 included fifty patients and group 2 included 24 patients. There were no significant differences in surgical outcomes or complication rates between the two groups (p > 0.05 for all). There were no differences in pelvic nodal counts or length of stay.
Robotic surgery was found to be feasible and safe for obese patients with endometrial cancer. Its widespread application needs a larger sample with longer follow-up.
本研究的目的是评估机器人手术对肥胖（体重指数（BMI）≥30kg/m）早期子宫内膜癌患者的临床疗效。
本研究是一项对2008年至2017年接受机器人手术治疗早期子宫内膜癌的女性患者的回顾性研究。患者被分为BMI<30kg/m的患者（第1组）和BMI≥30kg/m的患者（第2组）。从病历中提取基本人口统计学数据和围手术期结果并进行比较。
第1组包括50例患者，第2组包括24例患者。两组之间的手术结果或并发症发生率无显著差异（所有p>0.05）。盆腔淋巴结计数或住院时间无差异。
机器人手术对肥胖子宫内膜癌患者是可行且安全的。其广泛应用需要更大样本量和更长随访时间。
